Results 111 to 120 of about 6,313 (203)

Short-Acting Insulin Reduction Strategies for Continuous Cycle Ergometer Exercises in Patients with Type 1 Diabetes Mellitus [PDF]

, 2017
Rabasa-Lhoret R, Tschakert G
core   +1 more source

Canagliflozin for primary and secondary prevention of cardiovascular events: results from the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)

, 2017
BACKGROUND : Canagliflozin is a sodium glucose cotransporter 2 inhibitor that significantly reduces the composite of cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke in patients with type 2 diabetes mellitus and elevated ...
CANVAS Program Collaborative Group, De Zeeuw, D, Desai, M, Erondu, N, Fabbrini, E, Fulcher, G, Li, Q, Mahaffey, KW, Matthews, DR, Neal, B, Perkovic, V, Shaw, W, Sun, T   +12 more
core   +1 more source

Die Beurteilung des Arzneimittelmarkt-Neuordnungsgesetzes (AMNOG) aus Sicht der gesetzlichen Krankenkassen [PDF]

, 2016
Die Umfrage unter einzelnen gesetzlichen Krankenkassen in Deutschland hatte zwei wesentliche Ziele: Zum einen sollten rückblickend die Prozesse, Wirkmechanismen und Ergebnisse des AMNOG betrachtet werden, um zu erheben, wie dies aus der Perspektive ...
Martschinke, Belinda, Tunder, Ralph
core  

Glycemic Control in a Real-Life Setting in Patients with Type 2 Diabetes Treated with IDegLira at a Single Swiss Center [PDF]

, 2017

core   +1 more source

The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical Trial [PDF]

, 2016
Abhishek Mishra, Bruce W. Bode, Jean-Pierre Courrèges, Louis B. Chaykin, Lucine M. Lehmann, Richard W. Simpson, Sultan Linjawi, Yehuda Handelsman   +7 more
core   +1 more source

IDegLira Versus Alternative Intensification Strategies in Patients with Type 2 Diabetes Inadequately Controlled on Basal Insulin Therapy [PDF]

, 2015

core   +1 more source

Pharmacokinetics and pharmacodynamics of insulin glargine 300 U/mL in the treatment of diabetes and their clinical relevance [PDF]

, 2016
David Owens
core   +1 more source

Model for Simulating Fasting Glucose in Type 2 Diabetes and the Effect of Adherence to Treatment. [PDF]

, 2017
Aradóttir, Tinna Björk, Bengtsson, Henrik, Boiroux, Dimitri, Jørgensen, John Bagterp, Kildegaard, Jonas, Orden, Brad V.   +5 more
core   +1 more source

Emulating a Randomized Controlled Trial of Long-Acting Insulins and Cardiovascular Events Using Real-World Data for Patients With Type 2 Diabetes. [PDF]

Pharmacoepidemiol Drug Saf
Wang W, Reynier P, Webster-Clark M, Yu OHY, Brunetti V, Filion KB.   +5 more
europepmc   +1 more source

Insulin edema in slowly progressive type 1 diabetes: improvement following adjustment of insulin therapy. [PDF]

Diabetol Int
Okamura E, Harada N, Okuno K, Yamamoto K, Murakami T, Ueda Y, Yabe D.   +6 more
europepmc   +1 more source